Clinical Trial Update: Pom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pom-dex vs pom-cyclo-dex in multiple myeloma patients during lenalidomide maintenance; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• pom-cyclo-dex (pomalidomide + cyclophosphamide + dexamethasone)
• pom-dex (pomalidomide + dexamethasone)

Snippet

Sponsor: Fondazione EMN Italy Onlus | Conditions: Multiple Myeloma | Phase 3 | Status: TERMINATED | Results posted: 2021-03-10